⌘K

Login Start Free

Home/Filings/4/0000899243-20-032257

4//SEC Filing

Western Standard Partners QP, L.P. 4

Accession 0000899243-20-032257

CIK 0001274792other

View on SEC.gov Company Profile

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 4:05 PM ET

Size

14.7 KB

Accession

0000899243-20-032257

Insider Transaction Report

Form 4

Period: 2020-11-24

MERRIMACK PHARMACEUTICALS INCMACK

DirectorOther

Transactions

Purchase
Common Stock
2020-11-24$3.65/sh+18,014$65,751→ 315,757 total(indirect: See footnote)
Purchase
Common Stock
2020-11-24$3.65/sh+51,074$186,420→ 873,088 total(indirect: See footnote)

WESTERN STANDARD PARTNERS LP

Other

Transactions

Purchase
Common Stock
2020-11-24$3.65/sh+51,074$186,420→ 873,088 total(indirect: See footnote)
Purchase
Common Stock
2020-11-24$3.65/sh+18,014$65,751→ 315,757 total(indirect: See footnote)

Western Standard LLC

Other

Transactions

Purchase
Common Stock
2020-11-24$3.65/sh+18,014$65,751→ 315,757 total(indirect: See footnote)
Purchase
Common Stock
2020-11-24$3.65/sh+51,074$186,420→ 873,088 total(indirect: See footnote)

Western Standard Partners QP, L.P.

Other

Transactions

Purchase
Common Stock
2020-11-24$3.65/sh+18,014$65,751→ 315,757 total(indirect: See footnote)
Purchase
Common Stock
2020-11-24$3.65/sh+51,074$186,420→ 873,088 total(indirect: See footnote)

Footnotes (2)

[F1]The shares are directly held by WSP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
[F2]The shares are directly held by WSP QP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MERRIMACK PHARMACEUTICALS INC

CIK 0001274792

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001544857

Filing Metadata

Form type: 4
Filed: Nov 26, 7:00 PM ET
Accepted: Nov 27, 4:05 PM ET
Size: 14.7 KB

View on SEC.gov